These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30048800)

  • 1. Two strategies to enhance ungual drug permeation from UV-cured films: Incomplete polymerisation to increase drug release and incorporation of chemical enhancers.
    Kerai LV; Bardés J; Hilton S; Murdan S
    Eur J Pharm Sci; 2018 Oct; 123():217-227. PubMed ID: 30048800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases.
    Kerai LV; Hilton S; Murdan S
    Int J Pharm; 2015 Aug; 492(1-2):177-90. PubMed ID: 26187167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of polyethylene glycols on the trans-ungual delivery of terbinafine.
    Nair AB; Chakraborty B; Murthy SN
    Curr Drug Deliv; 2010 Dec; 7(5):407-14. PubMed ID: 20955143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UV-curable gels as topical nail medicines:In vivo residence, anti-fungal efficacy and influence of gel components on their properties.
    Kerai LV; Hilton S; Maugueret M; Kazi BB; Faull J; Bhakta S; Murdan S
    Int J Pharm; 2016 Nov; 514(1):244-254. PubMed ID: 27863669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
    Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
    Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement.
    Brown MB; Khengar RH; Turner RB; Forbes B; Traynor MJ; Evans CR; Jones SA
    Int J Pharm; 2009 Mar; 370(1-2):61-7. PubMed ID: 19071202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.
    Rizi K; Xu K; Begum T; Faull J; Bhakta S; Murdan S
    Int J Pharm; 2022 Feb; 614():121437. PubMed ID: 34973408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-ungual iontophoretic delivery of terbinafine.
    Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
    J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
    Kreutz T; de Matos SP; Koester LS
    Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate.
    Kobayashi Y; Miyamoto M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1797-802. PubMed ID: 9845958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of different formulations for drug delivery through the nail plate.
    Vejnovic I; Simmler L; Betz G
    Int J Pharm; 2010 Feb; 386(1-2):185-94. PubMed ID: 19941943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
    Patel MM; Vora ZM
    Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
    Nair AB; Sammeta SM; Vaka SR; Narasimha Murthy S
    J Pharm Pharmacol; 2009 Apr; 61(4):431-7. PubMed ID: 19298688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
    Vejnovic I; Huonder C; Betz G
    Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.
    Nair AB; Sammeta SM; Kim HD; Chakraborty B; Friden PM; Murthy SN
    Int J Pharm; 2009 Jun; 375(1-2):22-7. PubMed ID: 19481686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
    Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
    J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into keratinolytic enzymes to enhance ungual drug delivery.
    Mohorcic M; Torkar A; Friedrich J; Kristl J; Murdan S
    Int J Pharm; 2007 Mar; 332(1-2):196-201. PubMed ID: 17097244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.